Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes

BMC Ophthalmol. 2023 Jul 6;23(1):301. doi: 10.1186/s12886-023-03065-2.

Gaspard Suc^{1

2}, Gregory G Schwartz³, Shaun G Goodman^{4

5}, J Wouter Jukema^{6

7}, Garen Manvelian⁸, Yann Poulouin⁹, Robert Pordy⁸, Michel Scemama¹⁰, Michael Szarek^{11

12}, Ph Gabriel Steg^{13

14

15

16

17}; ODYSSEY OUTCOMES Investigators

¹ Université Paris-Cité, INSERM_U1148/LVTS, Paris, France.
² Assistance Publique-Hôpitaux de Paris, HôpitalBichat, Paris, France.
³ Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA.
⁴ Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada.
⁵ St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
⁶ Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
⁷ Netherlands Heart Institute, Utrecht, the Netherlands.
⁸ Regeneron Pharmaceuticals, Tarrytown, NY, USA.
⁹ IT&M Stats, Neuilly-Sur-Seine, France.
¹⁰ Sanofi, Chilly-Mazarin, France.
¹¹ Downstate School of Public Health, State University of New York, Brooklyn, NY, USA.
¹² CPC Clinical Research and Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA.
¹³ Université Paris-Cité, INSERM_U1148/LVTS, Paris, France. gabriel.steg@aphp.fr.
¹⁴ Assistance Publique-Hôpitaux de Paris, HôpitalBichat, Paris, France. gabriel.steg@aphp.fr.
¹⁵ Institut Universitaire de France, Paris, France. gabriel.steg@aphp.fr.
¹⁶ FACT (French Alliance for Cardiovascular Trials), INSERM U-1148, Paris, France. gabriel.steg@aphp.fr.
¹⁷ Département de Cardiologie, AP-HP Hôpital Bichat, 46 Rue Henri Huchard, Paris, 75018, France. gabriel.steg@aphp.fr.

No abstract available

Publication types